Product Launches

11
Jul
IQIVA Sheds Light on a Problem - Lachman Blog

Generic Approvals vs. Launches – IQVIA Sheds Light on a Problem

In a report titled Trends in Drug Shortages and ANDA Approvals in the U.S. (here) released by IQVIA on July 10th, IQVIA shines a light on the actual launch of generic drug products. The report indicates that “[b]etween 2013 and Q1 2024, 37% of approved generics had not launched, and it often takes over four […]

Read More